ArticleMetabolic brain disease2011

Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.

Suzan Dziennis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.